|
Statement of Compliance
The Western Institutional Review Board (WIRB) is in compliance with Good Clinical
Practices as defined under the U.S. Food and Drug Administration (FDA) regulations
and the International Conference on Harmonisation (ICH) guidelines. This statement
also appears on all Certificates of Approval issued by WIRB.
Working With WIRB for IRB Review - An Overview
The Western Institutional Review Board is composed of several individual review
panels. Each WIRB panel consists of nine standing members and their designated alternates.
Panel Structure and Schedule
- Monday: Panels 1, 7 & 14
- Tuesday: Panels 2 & 5
- Wednesday: Panels 3, 11 & 14
- Thursday: Panels 4, 12, & 13
- Friday: Panels 6, 8 & 14
- Bi-Weekly: Panel 10 (Canada)
- Investigator Focused Meetings – Daily
New protocols are assigned to panels based on both the specialty required to review
the protocol and the next available panel meeting. The upper right corner of the
WIRB Certificate of Approval displays the panel assignment of the related protocol.
Once a protocol is assigned to a particular panel, all subsequent reviews for that
protocol (new investigators, changes in research and continuing review) are carried
out by that panel. Reviews for investigators at Canadian locations are assigned
to the WIRB Canadian panel; therefore, a protocol taking place in both the United
States and Canada can be assigned to both a U.S. panel and the Canadian panel.
WIRB's Internet tracking system can be
used to track the status of a submission, including when it has been scheduled for
board. To learn more about the tracking system or WIRB's panel structure, or to
determine the panel assignment of a particular protocol, call Client Services at
(360) 252-2500 or e-mail clientservices@wirb.com.
back to top of page
|